Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma: A Phase Ib Study
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2018
At a glance
- Drugs TG 02 S*Bio/Adastra Pharmaceuticals (Primary) ; Temozolomide
- Indications Anaplastic astrocytoma; Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms STEAM
- 31 Aug 2018 Biomarkers information updated
- 07 Jun 2018 Status changed from not yet recruiting to recruiting.
- 16 Feb 2018 Planned End Date changed from 1 Jun 2020 to 1 Aug 2020.